Canaccord Genuity Reiterates Buy Rating on Guardant Health, Inc. (GH)

Market Context

Guardant Health, Inc. operates in the Healthcare sector. The stock currently trades at $160.48 with a market capitalization of $12.6B. The stock has gained 213.6% over the past 52 weeks.

Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Guardant Health, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Guardant Health, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 14, 2026	Canaccord Genuity	Buy	N/A
Jul 09, 2026	Morgan Stanley	Overweight	N/A
Jul 08, 2026	Citigroup	Buy	N/A
Jul 06, 2026	B of A Securities	Buy	N/A
Jul 06, 2026	Evercore ISI Group	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View GH Stock Page